Americans Face Challenges to Access GLP-1 Medication -- Market Talk

Dow Jones

2024/11/14

1450 ET - Americans are struggling to get their hands on branded GLP-1 medications, a hormone that helps regulate blood sugar, appetite, and digestion. Him and Hers, a health and wellness company, said that nearly 80,000 people have reported they can't get access to the drug, especially those in states where obesity is higher. To address this, Him & Hers introduced a GLP-1 supply tracker, allowing users to share their experiences and push for better access. This move could support the company's case for compounded versions of the drug, which the FDA is reviewing. Shares rise 3.7% to $27.67. (kailyn.rhone@wsj.com; @onlykailyn)

(END) Dow Jones Newswires

November 13, 2024 14:50 ET (19:50 GMT)

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2483514638"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2483514638\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2483514638?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-14 03:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2483514638","market":"fut","top_or_hot":-1,"title":"Americans Face Challenges to Access GLP-1 Medication -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1450 ET - Americans are struggling to get their hands on branded GLP-1 medications, a hormone that helps regulate blood sugar, appetite, and digestion. Him and Hers, a health and wellness company, said that nearly 80,000 people have reported they can't get access to the drug, especially those in states where obesity is higher. To address this, Him &amp; Hers introduced a GLP-1 supply tracker, allowing users to share their experiences and push for better access. This move could support the company's case for compounded versions of the drug, which the FDA is reviewing. Shares rise 3.7% to $27.67. (kailyn.rhone@wsj.com; @onlykailyn) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 13, 2024 14:50 ET (19:50 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Americans Face Challenges to Access GLP-1 Medication -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmericans Face Challenges to Access GLP-1 Medication -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2024-11-14 03:50</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1450 ET - Americans are struggling to get their hands on branded GLP-1 medications, a hormone that helps regulate blood sugar, appetite, and digestion. Him and Hers, a health and wellness company, said that nearly 80,000 people have reported they can't get access to the drug, especially those in states where obesity is higher. To address this, Him &amp; Hers introduced a GLP-1 supply tracker, allowing users to share their experiences and push for better access. This move could support the company's case for compounded versions of the drug, which the FDA is reviewing. Shares rise 3.7% to $27.67. (kailyn.rhone@wsj.com; @onlykailyn) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 13, 2024 14:50 ET (19:50 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4144","symbol_name":"石油与天然气的储存和运输","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2483514638","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2483514638","pubTimestamp":1731527400,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"1450 ET - Americans are struggling to get their hands on branded GLP-1 medications, a hormone that helps regulate blood sugar, appetite, and digestion. Him and Hers, a health and wellness company, said that nearly 80,000 people have reported they can't get access to the drug, especially those in states where obesity is higher. To address this, Him & Hers introduced a GLP-1 supply tracker, allowing users to share their experiences and push for better access. This move could support the company's case for compounded versions of the drug, which the FDA is reviewing. Shares rise 3.7% to $27.67. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4144":"石油与天然气的储存和运输","HIMS":"Hims & Hers Health Inc.","BK4590":"PTP","BK4196":"保健护理服务","GLP":"Global Partners Lp"},"translate_title":"美国人在获得GLP-1药物方面面临挑战——Market Talk","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GLP":1,"HIMS":0.9},"content_text":"1450 ET - Americans are struggling to get their hands on branded GLP-1 medications, a hormone that helps regulate blood sugar, appetite, and digestion. Him and Hers, a health and wellness company, said that nearly 80,000 people have reported they can't get access to the drug, especially those in states where obesity is higher. To address this, Him & Hers introduced a GLP-1 supply tracker, allowing users to share their experiences and push for better access. This move could support the company's case for compounded versions of the drug, which the FDA is reviewing. Shares rise 3.7% to $27.67. (kailyn.rhone@wsj.com; @onlykailyn) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 13, 2024 14:50 ET (19:50 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}